Cardiovascular Systems (CSII) Financials

$20.00

$0.00 (0.00%)

As on 02-May-2023 09:30EDT

Market cap

$844 Mln

Revenue (TTM)

$240 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	--	--	--	--	--	--
Operating Profit (EBIT)	--	--	--	--	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	--	--	--	--	--	--
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	--	--	--	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Shareholder's Funds	--	--	--	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	--	--	--	--	--	--
Total Liabilities	--	--	--	--	--	--

Assets ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Non-Current Assets	89.55	80.83	67.90	51.83	38.50	35.74
Current Assets	221.96	241.85	284.67	287.69	180.08	167.61
Total Assets	348.27	322.68	352.57	339.52	218.58	203.35
Total Debt*	20.12	20.30	20.60	20.82	20.97	21.06
Net Current Assets	185.20	201.89	230.02	243.18	137.73	130.15

Cashflow ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Cash From Operating Activities	--	--	--	--	--	--
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
ROCE (%)	--	--	--	--	--	--
ROE (%)	--	--	--	--	--	--
ROA (%)	--	--	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	--	--	--	--
Net Profit Growth (%)	--	--	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	--	--	--	--
Close Price ($)	--	--	--	--	--	--
High Price ($)	--	--	--	--	--	--
Low Price ($)	--	--	--	--	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	--	--	--	--	--	--
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.